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Patients with asymptomatic or minimally symptomatic mitral 
regurgitation present a dilemma for the clinician. &cause the 
valve lesion itsalf cawes increased preload and decreavd 
afterload, the normal response of the left ventricle to mitral 
regurgitation should be a nmmal or low end-systcdll volume. 
with a hyperdynamic ejection fraction fhat dsclines after 
corrective surgery (1). Assuming that there is significant (mod- 
erately severe or severe) mitral regurgitation without a primary 
coranaty or myocsrdial process, signilkaat secondary tnyocar- 
dial dysfunction should be susp-xred if the end-systolic left 
ventricular volume is even mildly increased or the ejection 
fraction is low normal or mildly decreased. 
The repart by Enriqun-Sarano et al. (2) in this issue of the 
Journal agrees with previous studies s’ aesting that prcopcr- 
alive depression of left ventricular ejection fraction (I,$ or 
elevalian of end-systolic ventricular size (4-6) is predktive of 
reduced cjecdon fraction after surgical correction of mitral 
regurgitation. 
lntarplay kehveen venirlcular slza sttd fttttcilon. Enriquw- 
Sarano et al. further suggest hat preoperative jection fraction 
and end-systolic diameter by echccardiography fogrrhrr have 
more predictive power than either one alone. For example, a 
patient with ejection fraction <SO% and end.systolic diameter 
>45 mm has a >70% likelihood of postoperative ven~rkular 
dysfunction (Table 3, Fig. 4 121). No previous study has 
demonstrated the interaction of these two easily obtainable, 
noninvasive variables in as usable a way. 
The potential for occult left ventricular dysfunction in 
mitral regurgitation has been recognized in the past. Many 
previoussludies have attempted to determine a simple guida 10 
the optimal time for operative intervention in asymptomatic 
patients. Other echwardiographic variables studied include 
the end-systolic wall stress/end-systolic volume index ratio 
(6-E) and the systolic diameter/wall thickness ratio (9). Both 
showed significant, although not independent, effects on past- 
operative ejection fraclion in the pnsent study. One group 
found a correlation between left atrial size and outemc (9), 
unlike the current study. Not included in the current srudy 
were Doppleideti~ed estimates of pulmonary pressure (1) and 
the rate of change in left ventrimlar pressure over time (IO), 
end+& streswtmin (11) and myocardial elastance (12), all 
of whkh have also been considered important factors in this 
d&ion. Unfortunately, a practical load-independent mea- 
surement of left ventr&lar ~&n&n thst would cleanly avoid 
the ~rablems with eicction fraction hss vet not been found. In 
the &sent study. e~dsystolic diamete; and ejection Fraction 
acmunted for 52% of the variability in postoperative jection 
fraction (2). 
ItttcgraUan d clinical and echmrdiqmpbic &la As- 
sessmcntri d left veatrfcular size and function are only one 
mmponent of this complex clinical decision (13.14). In evalu- 
sting patients with pure isolated mitral regurgitation who are 
being considered for mitral surgety, I consider live elements 
1) symptoms, 2) left ventricular size, 3) left ventricular hmc- 
Con, 4) significant pulmonaty hyperten& and 5) chronic w 
recuteat atrial tibtillaCm (14-18). If two or mare of thez 
f~snabnarmalasaRsultofthe~,e*etiveopera~M 
shouklbcmnskJered.ffooeormorcarcpattiallyabnomlal,the 
patieat s4KHdd bs fcdlwed with Cliakal and ocwphie 
study every 6 to 12 months. Trends toward fuxtic& &tcrima- 
tionoutsidetheinterolacrva(ionenor.-Smmforknventrieular 
diameter (19,20), are ako an impma& considcraticm. 
Surgical repair may be indicated aarliir or later depending 
on conmmitant mitral stenosis, abmxmalities of other valves, 
caronaryanerydixasc,endocardiliSrightventiieulardysfunc- 
lion, patkatdial dkeav or nottcatdiac factors influencing 
symptoms or operative rfsk. In patisnts with signilicant cm-o. 
nary disease or kchemic mitral ragwgha~ian, me shwld be 
more aggressive whh surgkal racmttme ndalions or clme fol- 
lwttp, or both (18,21). Even a sittgk bypa&le coronary 
anety lesion in addition to severe mitral regurgitation may be 
a valid htdkaGan for earlier surgical intemntion. In the SW 
by EnriqucbSararm at al (2), the group with lxhemic mitral 
reaueitaGon had an ES& hwfdenCe of +sW~~rative left 
ve&&ar dysfunciion centwed with 32% in the~tmnischemic 
group (2). 
Mltral npllr veraw raplaccmml. The choke of mitral 
repair versus replacement should also &act the decirian on 
liming of mitral operation. 1 dkagtee with the cumnl study, 
whiih states that this cannot be incotporared into current 
preoperative decisions. Further cvaIuaGon of their results to 
determine the effwt on ejection fraction of repair or replace- 
meni might te interesting. 
In the 197fh, the indications for conection of mitral regw 
gitation ware New York Heart Association hut&mal class III 
symptoms that muld not be conttolled with medical manage- 
ment (22-24). At that time, the only surgical option was valve 
replacement. The risks were death or development of pmgres- 
sive heart failure from myocardial dysfunction. Clinicians 
made decisions on the basis of echoeardiograpbic predictors of 
myccardial dysfunction. The clinical solution was to delay 
operation as long as possible. As a resuh, surgical therapy far 
mitral regurgitation was associated with lower long-term 
survival rates than any other common isoiated valve lesion. 
including mitral stenosis, aortic regurgitation and aurtic steno- 
sis (25). 
Today, the indications fur operariou for mitral regurgitation 
are d&rent because valve repair is a feasible surg&ioptiou 
performed by experienced surgeons in 70% of cases (26). The 
risks of timely repair are low, with only a 2% periopcrative 
mortality rate (26.27), whereas the risks of d&v are higher. 
and& replacement may be required. which hai a 5% I: 8% 
periopwative mortality risk rate and a much hither chance Jf 
“prosthetic valve diseases.” including prosthetic endocarditis. 
ventricular dysfunction, inherent stenosis of the prosthesis aid 
complications fmm thrombaemboli or hemorrhage (28). The 
way in which clinicians make decisions hould reflect a lcarncd 
appraisal of likely surgical outcome, including that of valve 
repair versus replacement (29), which is at I :ast as important in 
preoperative decisions as is the presence of cccull myncardml 
dysfunction. 
Echocardiography can accurately detemlinr the mechanism 
of mitti regurgitation (30). The likelihood of repair wsus 
replacement depends on the mechanism of dysfunction and 
.vuries from 20% to 90% (26). The feasibility of repair vwsus 
replacement also varies with the skills and experience of the 
individual surgeon (31). Whether repair 01 replucement is 
perfamxd substantially atTccts periupemtive risk (28) and 
postoperative myocardial function (32). 
Chuaing Ihe “pldett mumenl” for operalion. Both surgi- 
cal and medical options have inherent risks and benefits that 
should be considered carefully. Dcspitc were mitml repurg- 
tatian. it is difficult to expose uu asymptomntic patient to minor 
or major periopxative complications which occurred in 8% in 
the current study (2). By contrast, the pntienr managed med- 
ically should be informed of the potential far inter4 mmpli- 
cations, endwxaditis or progression of disease, which could 
result in un unrepoimble valve and death. Recognizing the 
risks of waitin& some patients, including some with symptoms, 
may choux the “stitch in time” philosophy before two of the 
five categories previously listed ire ful$ ohnomml. 
The optimal iime for mitral surgery should be chusen on the 
basis of a comprehensive valuation of t!~e individual patient 
and the risks ond benefits of either the medical or surgicul 
approach. Our understanding of this field has beeu enhanced 
by the Enriquez-Snrano et al. study, the largest of its kind 
published to date. In patients with mitral regurgitation. the 
echucardiogrrm should be used for objective ussessment of lefi 
wnnicular size and fincuncrion and for determining the mecho- 
nism of rhe wlvular dy@nclion, both of whtcb impact the 
optimal timing. the “golden moment” for operative interen- 
tion. 

